Drugs / autologous Stem Cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01834053 | Sep 2014 → Jun 2016 | Huntington disease | Chaitanya Hospital, Pune | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous Stem Cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01834053 ↗ |
| Known as | MNCs | “Intrathecal transplantation of autologous 100 millions Stem cells{MNCs } per dose'” NCT01834053 ↗ |
| Route | Intrathecal | “Transfer of autologous Stem cell( MNCs) intrathecally” NCT01834053 ↗ |